|

Preoperative i.v. Iron Substitution in Patients With Colon Cancer

RECRUITINGN/ASponsored by Helsinki University Central Hospital
Actively Recruiting
PhaseN/A
SponsorHelsinki University Central Hospital
Started2020-10-01
Est. completion2024-12-31
Eligibility
Age18 Years – 100 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04653181

Summary

About 70% of colon cancer patients are anemic. Preoperative anemia in patients with colorectal cancer is associated with both impaired disease-free survival and overall survival. The purpose of this study is to compare the effects of preoperative iv iron substitution on postoperative recovery in preoperatively anemic (male Hb \<130, female Hb \<120) and iron deficient colon cancer patients in a prospective setup. As a primary outcome, the effect of iv-iron substitution on postoperative complications is investigated.

Eligibility

Age: 18 Years – 100 YearsHealthy volunteers accepted
Inclusion Criteria:

* Age\> 18 years
* Dg: Colon ca
* The planned measure: the colon resection
* Men: Hb \<130, women: Hb \<120 and iron deficiency (elevated TfR, low TrFesat or low ferritin)

Exclusion Criteria:

* hyperreactivity for Ferinject
* haemochromatosis
* refusal for participation

Conditions2

CancerColon Cancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.